SCHEMBL12225751

SCHEMBL12225751

CNS(=O)(=O)c1ccc(Br)c(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
CASP6 P55212 1/20 0.50
PKM P14618 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 2/20 0.45
METAP2 P50579 1/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
FLT1 P17948 1/20 0.43
FLT4 P35916 1/20 0.43
KDR P35968 1/20 0.43
POLB P06746 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPK1 P28482 1/20 0.42
MAPT P10636 1/20 0.42
CA12 O43570 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12225750 0.83 ALDH1A1 (0.58) HSD17B10MEN1KMT2ACASP6PKM
SCHEMBL19119211 0.81 POLB (0.59) HSD17B10MEN1KMT2AL3MBTL1LMNA
SCHEMBL2825786 0.81 ALDH1A1 (0.62) HSD17B10MEN1KMT2ACASP6L3MBTL1
SCHEMBL17202484 0.81 LMNA (0.64) HSD17B10MEN1KMT2ACASP6PKM
SCHEMBL3878089 0.81 MAPK1 (0.62) POLBKDM4EMAPK1CA1CA2
SCHEMBL28650672 0.81 CA2 (0.49) HSD17B10MEN1KMT2AL3MBTL1LMNA
SCHEMBL12225752 0.80 CA12 (0.54) HSD17B10MEN1KMT2ACASP6PKM
SCHEMBL13543494 0.80 CYP3A4 (0.52) HSD17B10MEN1KMT2AL3MBTL1LMNA
SCHEMBL4844487 0.80 KMT2A (0.50) MEN1KMT2ACASP6PKML3MBTL1
SCHEMBL30602792 0.80 LMNA (0.45) HSD17B10MEN1KMT2AL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044075-B2 IL-8 receptor antagonists GLAXOSMITHKLINE (US) 2011-10-25 US disclosed
US-8044075-B2 IL-8 receptor antagonists GLAXOSMITHKLINE (US) 2011-10-25 US disclosed
US-20100298387-A1 IL-8 Receptor Antagonists SMITHKLINE BEECHAM CORPORATION 2010-11-25 US disclosed
US-20100298387-A1 IL-8 Receptor Antagonists SMITHKLINE BEECHAM CORPORATION 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298387-A1 IL-8 Receptor Antagonists CXCL8, CCR8, IL1RN HSD17B10 3179/4885MEN1 4425/4885KMT2A 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.